Drug Co. Dava Pays $11M To End Medicaid Rebate Suit
Drugmaker Dava Pharmaceuticals Inc. has agreed to pay $11 million to settle a suit alleging it misreported drug prices to reduce its payments under a Medicaid rebate program, the U.S. Department...To view the full article, register now.
Already a subscriber? Click here to view full article